Stay updated on Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page.

Latest updates to the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page
- ChecktodayChange DetectedThe study record for the denosumab and immune checkpoint inhibitor trial in unresectable or metastatic melanoma is displayed, including its treatment arms, eligibility criteria, locations, and outcome measures.SummaryDifference68%

- Check7 days agoChange DetectedThe 403 error and NIH transition notice are no longer shown. The study-record area appears blank, while the site navigation and footer remain.SummaryDifference2%

- Check14 days agoChange DetectedA site-wide notice announces NIH website updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check21 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study record page now displays a 403 Forbidden error for the URL, indicating access is blocked. The screen shows a 403 message and a Home button, reflecting an access restriction rather than new content on the study page.SummaryDifference0.5%

Stay in the know with updates to Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab with Checkpoint Inhibitors in Melanoma Clinical Trial page.